Leung HY - Search Results

1

Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer.

Ahmad I, Singh LB, Yang ZH, Kalna G, Fleming J, Fisher G, Cooper C, Cuzick J, Berney DM, Møller H, Scardino P, Leung HY. Ahmad I, et al. Among authors: leung hy. Br J Cancer. 2013 Jan 15;108(1):149-54. doi: 10.1038/bjc.2012.510. Br J Cancer. 2013. PMID: 23321517 Free PMC article.

2

ERK5 signalling in prostate cancer promotes an invasive phenotype.

Ramsay AK, McCracken SR, Soofi M, Fleming J, Yu AX, Ahmad I, Morland R, Machesky L, Nixon C, Edwards DR, Nuttall RK, Seywright M, Marquez R, Keller E, Leung HY. Ramsay AK, et al. Among authors: leung hy. Br J Cancer. 2011 Feb 15;104(4):664-72. doi: 10.1038/sj.bjc.6606062. Epub 2011 Jan 25. Br J Cancer. 2011. PMID: 21266977 Free PMC article.

3

Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer.

Armstrong K, Ahmad I, Kalna G, Tan SS, Edwards J, Robson CN, Leung HY. Armstrong K, et al. Among authors: leung hy. Br J Cancer. 2011 Oct 25;105(9):1362-9. doi: 10.1038/bjc.2011.367. Epub 2011 Sep 27. Br J Cancer. 2011. PMID: 21952621 Free PMC article.

4

NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression.

McCall P, Bennett L, Ahmad I, Mackenzie LM, Forbes IW, Leung HY, Sansom OJ, Orange C, Seywright M, Underwood MA, Edwards J. McCall P, et al. Among authors: leung hy. Br J Cancer. 2012 Oct 23;107(9):1554-63. doi: 10.1038/bjc.2012.372. Br J Cancer. 2012. PMID: 23093296 Free PMC article.

5

Androgens modulate autophagy and cell death via regulation of the endoplasmic reticulum chaperone glucose-regulated protein 78/BiP in prostate cancer cells.

Bennett HL, Fleming JT, O'Prey J, Ryan KM, Leung HY. Bennett HL, et al. Among authors: leung hy. Cell Death Dis. 2010 Sep 9;1(9):e72. doi: 10.1038/cddis.2010.50. Cell Death Dis. 2010. PMID: 21364676 Free PMC article.

6

Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis.

Ahmad I, Patel R, Liu Y, Singh LB, Taketo MM, Wu XR, Leung HY, Sansom OJ. Ahmad I, et al. Among authors: leung hy. Cell Death Dis. 2011 Mar 3;2(3):e124. doi: 10.1038/cddis.2011.7. Cell Death Dis. 2011. PMID: 21368895 Free PMC article.

7

β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation.

Ahmad I, Morton JP, Singh LB, Radulescu SM, Ridgway RA, Patel S, Woodgett J, Winton DJ, Taketo MM, Wu XR, Leung HY, Sansom OJ. Ahmad I, et al. Among authors: leung hy. Oncogene. 2011 Jan 13;30(2):178-89. doi: 10.1038/onc.2010.399. Epub 2010 Sep 6. Oncogene. 2011. PMID: 20818428 Free PMC article.

8

Darby S, Murphy T, Thomas H, Robson CN, Leung HY, Mathers ME, Gnanapragasam VJ. Darby S, et al. Among authors: leung hy. Br J Cancer. 2009 Dec 1;101(11):1891-9. doi: 10.1038/sj.bjc.6605379. Epub 2009 Nov 3. Br J Cancer. 2009. PMID: 19888221 Free PMC article.

9

Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients.

Willder JM, Heng SJ, McCall P, Adams CE, Tannahill C, Fyffe G, Seywright M, Horgan PG, Leung HY, Underwood MA, Edwards J. Willder JM, et al. Among authors: leung hy. Br J Cancer. 2013 Jan 15;108(1):139-48. doi: 10.1038/bjc.2012.480. Epub 2012 Dec 4. Br J Cancer. 2013. PMID: 23321516 Free PMC article.

10

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.

Gnanapragasam VJ, Leung HY, Pulimood AS, Neal DE, Robson CN. Gnanapragasam VJ, et al. Among authors: leung hy. Br J Cancer. 2001 Dec 14;85(12):1928-36. doi: 10.1054/bjoc.2001.2179. Br J Cancer. 2001. PMID: 11747336 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page